The role of antagonists to acid secretion.
D015064:16,16-Dimethylprostaglandin E2 / Q000627:therapeutic use; D001570:Benzodiazepinones / Q000627:therapeutic use; D002927:Cimetidine / Q000627:therapeutic use / Q000031:analogs & derivatives; D005663:Furans / Q000627:therapeutic use; D005744:Gastric Acid / Q000378:metabolism*; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D006146:Guanidines / Q000627:therapeutic use; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D010890:Pirenzepine; D011377:Proglumide / Q000627:therapeutic use; D011899:Ranitidine; D013004:Somatostatin / Q000627:therapeutic use; D013844:Thiazoles / Q000627:therapeutic use
D001570:Benzodiazepinones; D005663:Furans; D006146:Guanidines; D006635:Histamine H2 Antagonists; D013844:Thiazoles; D010890:Pirenzepine; D013004:Somatostatin; D002927:Cimetidine; D011899:Ranitidine; D011377:Proglumide; C023990:tiotidine; D015064:16,16-Dimethylprostaglandin E2